Amanote Research

Amanote Research

    RegisterSign In

Multiple Sclerosis: Therapeutic Pessimism.

BMJ
doi 10.1136/bmj.304.6837.1260
Full Text
Open PDF
Abstract

Available in full text

Date

May 16, 1992

Authors
H. E. Webb
Publisher

BMJ


Related search

002 Therapeutic Lag in Relapsing Multiple Sclerosis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2019English

Erratum “Current Evidence and Therapeutic Strategies for Multiple Sclerosis”

Seminars in Neurology
Neurology
2008English

G Protein-Coupled Receptors as Therapeutic Targets for Multiple Sclerosis

Cell Research
Cell BiologyMolecular Biology
2012English

Motor Imagery in Multiple Sclerosis: Exploring Applications in Therapeutic Treatment

Journal of Neurophysiology
NeurosciencePhysiology
2019English

Clinical Features, Diagnosis and Therapeutic Strategies in Pediatric Multiple Sclerosis

Clinical and Experimental Neuroimmunology
NeuroscienceNeurologyImmunologyMicrobiology
2017English

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

Current Drug Target -Inflammation & Allergy
2004English

Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis

Clinical and Developmental Immunology
2012English

Multiple Sclerosis, Immunological, Diagnostic and Therapeutic Aspects. Current Problems in Neurology 3.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1988English

Multiple Sclerosis

Journal of Clinical Investigation
Medicine
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy